AzTrials
AzTrials

BrainNCT04317950

Cortical Activity During Vojta Stimulation in Healthy Adults

A study testing Vojta in people with Brain, run by Josue Fernandez Carnero at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The present study is focused on the importance of sensory stimuli at the tactile and proprioceptive level that occur during the activation of the pectoral area, following the treatment protocol of Vojta Therapy (VT), and which are the areas that are activated in the central nervous system (CNS) during stimulation, as… Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Brain
What is being tested?
Vojta
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
1 siteSpain
Study dates
8 Jan 2020to 15 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy adult population with no history of neurological disease or others that may affect the test.
  • Age between 18 and 50 years.
  • Not having addiction to alcohol or drugs at the time of the study.
  • Not knowing the basics of Vojta Therapy, or knowing the responses of stimuli when applying therapy.
  • Not having the pharmacological treatment that affects the functioning of the Central Nervous System and may interfere with the test results.

Who cannot join

  • Those who do not meet the inclusion criteria
  • Not having suffered ms-skeletal alterations in the last 6 months.
  • Known sensory abnormalities.
  • Diagnosis of some neurological pathology or condition that could alter the study such as pain, radiculopathy.
  • Refuse to sign the informed consent.
  • Claustrophobia.
Show all 13Show fewer
  • Those that can spoil the magnetic resonance image.
  • Be a carrier of some metallic material.
  • Pregnancy or nursing mother.
  • The contraindications of Vojta Therapy.
  • Acute diseases that present with fever and / or inflammation.
  • Vaccination with live germs, according to medical criteria (usually 10 days after vaccination).
  • In case of crystal bone disease, uncontrolled heart disease.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Roberto Cano de la Cuerda

    Alcorcón, Madrid, 28922

Other trials in Spain

About this study

Official title: Cortical Activity During Sensorial Tactile Stimulation in Healthy Adults. The Innate Patron Activation With Vojta Therapy.

The present study is focused on the importance of sensory stimuli at the tactile and proprioceptive level that occur during the activation of the pectoral area, following the treatment protocol of Vojta Therapy (VT), and which are the areas that are activated in the central nervous system (CNS) during stimulation, as well as muscle activity. For the activation record it will be used electroencephalography and electromyography electrods.

Read the detailed description

The relationship between intrinsic and extrinsic factors condition the development of the human being. The sensory organs are the main recipients of the information, thanks to them we are able to interact with the environment and register the influence of the stimuli inside the organism. The brain receives information from the environment through its senses.

At the tactile level the brain receives afferent information thanks to the activation of mechanoreceptors of the skin during interaction with the environment. The receivers encode the stimulus information and send it to the specific CNS structures. In these structures, the sensations received are combined and the stimulus is transformed into a perfectly elaborated response, both in a conscious and innate way.

Dr. Vojta showed in 1974 the locomotion reflects the result of the study of motor ontogenesis. This discovery was the demonstration of the existence of innate and preprogrammed motor patterns in Humans.

Most of the studies related to VT have showed the improvements obtained by the patients, validating it as a method of treatment and evidencing objective changes after its application. This research aim to go further and verify that cortical areas are activated during the application of an external and proprioceptive stimuli that are performed during the first phase of VT turning and which areas are responsible for producing and organizing the efferent response.

Conditions
Brain
Being tested
Vojta, Sham
Keywords
Electroencephalography, Electromyography, Tactile stimulation, Vojta therapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VojtaOther

    Reflex locomotion stimulus

  • ShamOther

    sham stimulus

Study groups in NCT04317950
Study groupRoleWhat they receive
Vojta groupOtherAll participants were properly instructed and signed an informed consent previous to the interventions. They were comfortably laid down on their back with eyes open, wearing the EEG cap and electromyography electrodes during the intervention. They were asked to remain relaxed and still during the whole process. After a first minute of resting, the experimental group received a continuous reflex locomotion stimulus during the next 8 minutes.
Receives: Other: Vojta
Control groupSham comparatorOn the contrary, the control group received a continuous sham stimulus during the next 8 minutes.
Receives: Other: Sham

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Electroencephalography (EEG)

    EEG power in alpha and beta bands

    Measured: 10 minutes per patient

  2. Electromyography (EMG)

    EMG power in Rectus abdominis, wrist extensors and tibialis anterior

    Measured: 10 minutes per patient

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Mar 2020
  2. Study start8 Jan 2020
  3. Primary completion1 Mar 2020
  4. Study completion15 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04317950
Sponsor's protocol ID
UEMURJC
Status last verified
Feb 2021
First submitted
28 Feb 2020
Last updated
10 Feb 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Sanz-Esteban I, Cano-de-la-Cuerda R, San-Martin-Gomez A, Jimenez-Antona C, Monge-Pereira E, Estrada-Barranco C, Serrano JI. Cortical activity during sensorial tactile stimulation in healthy adults through Vojta therapy. A randomized pilot controlled trial. J Neuroeng Rehabil. 2021 Jan 21;18(1):13. doi: 10.1186/s12984-021-00824-4.

    PubMed 33478517

Questions about this trial

What is this clinical trial studying?

A study testing Vojta in people with Brain, run by Josue Fernandez Carnero at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Electroencephalography (EEG) (time frame: 10 minutes per patient). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04317950, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in